Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate

References

• McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004; 4:240-5; PMID:15050943; http://dx.doi.org/10.1016/S1473-3099(04)00975-2
   PubMed Web of Science ®Google Scholar
• Massell BF, Honikman LH, Amezcua J. Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA 1969; 207:1115-9; PMID:5818242; http://dx.doi.org/10.1001/jama.1969.03150190037007
   PubMed Web of Science ®Google Scholar
• D'Alessandri R, Plotkin G, Kluge RM, Wittner MK, Fox EN, Dorfman A, Waldman RH. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus. J Infect Dis 1978; 138:712-8; PMID:368261; http://dx.doi.org/10.1093/infdis/138.6.712
   PubMed Web of Science ®Google Scholar
• Fox EN, Waldman RH, Wittner MK, Mauceri AA, Dorfman A. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest 1973; 52:1885-92; PMID:4719668; http://dx.doi.org/10.1172/JCI107372
   PubMed Web of Science ®Google Scholar
• FDA. Status of specific products; Group A Streptococcus. Federal Register January 5, 1979; 44(4):1544-9.
   Google Scholar
• FDA. Status of specific products; Group A Streptococcus. Federal Register December 2, 2005; 70:72197-9; PMID:16323338
   PubMedGoogle Scholar
• Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70:2171-7; PMID:11895984; http://dx.doi.org/10.1128/IAI.70.4.2171-2177.2002
   PubMed Web of Science ®Google Scholar
• Dale JB, Beachey EH. Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med 1985; 161:113-22; PMID:2578539; http://dx.doi.org/10.1084/jem.161.1.113
   PubMed Web of Science ®Google Scholar
• Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, Hunsakunachai S, Manmontri A, Good MF. Towards a vaccine for Rheumatic-Fever - Identification of a Conserved Target Epitope on M-Protein of Group-a Streptococci. Lancet 1994; 344:639-42; PMID:7520963; http://dx.doi.org/10.1016/S0140-6736(94)92083-4
   PubMed Web of Science ®Google Scholar
• Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 1997; 9:1723-33; PMID:9418133; http://dx.doi.org/10.1093/intimm/9.11.1723
   PubMed Web of Science ®Google Scholar
• Brandt ER, Hayman WA, Currie B, Pruksakorn S, Good MF. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Vaccine 1997; 15:1805-12; PMID:9364687; http://dx.doi.org/10.1016/S0264-410X(97)00178-3
   PubMed Web of Science ®Google Scholar
• Brandt ER, Hayman WA, Currie B, Carapetis J, Wood Y, Jackson DC, Cooper J, Melrose WD, Saul AJ, Good MF. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1996; 89:331-7; PMID:8958044; http://dx.doi.org/10.1046/j.1365-2567.1996.d01-754.x
   PubMed Web of Science ®Google Scholar
• Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, Good MF. Protection against Group A Streptococcus by immunization with J8-Diphtheria toxoid: Contribution of J8- and Diphtheria Toxoid-specific antibodies to protection. J Infect Dis 2003; 187:1598-608; PMID:12721940; http://dx.doi.org/10.1086/374800
   PubMed Web of Science ®Google Scholar
• Batzloff MR, Yan H, Davies MR, Hartas J, Lowell GH, White G, Burt DS, Leanderson T, Good MF. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus. J Infect Dis 2005; 192:1450-5; PMID:16170764; http://dx.doi.org/10.1086/466528
   PubMed Web of Science ®Google Scholar
• Batzloff MR, Hartas J, Zeng W, Jackson DC, Good MF. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization. J Infect Dis 2006; 194:325-30; PMID:16826480; http://dx.doi.org/10.1086/505146
   PubMed Web of Science ®Google Scholar
• Olive C, Batzloff M, Horvath A, Clair T, Yarwood P, Toth I, Good MF. Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun 2003; 71:2373-83; PMID:12704107; http://dx.doi.org/10.1128/IAI.71.5.2373-2383.2003
   PubMed Web of Science ®Google Scholar
• Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 2006; 193:1666-76; PMID:16703510; http://dx.doi.org/10.1086/504266
   PubMed Web of Science ®Google Scholar
• Gorton D, Govan B, Olive C, Ketheesan N. B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis. Infect Immun 2009; 77:2177-83; PMID:19273562; http://dx.doi.org/10.1128/IAI.01514-08
   PubMed Web of Science ®Google Scholar
• Pandey M, Langshaw E, Hartas J, Lam A, Batzloff MR, Good MF. A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia. J Immunol 2015; 194:5915-25; PMID:25980008; http://dx.doi.org/10.4049/jimmunol.1500157
   PubMed Web of Science ®Google Scholar
• Sheel M, Pandey M, Good MF, Batzloff MR. Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain. Clin Vaccine Immunol 2010; 17:127-33; PMID:19889937; http://dx.doi.org/10.1128/CVI.00256-09
   PubMed Web of Science ®Google Scholar
• Pandey M, Batzloff MR, Good MF. Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection. PLoS One 2009; 4:e5147; PMID:19340309; http://dx.doi.org/10.1371/journal.pone.0005147
   PubMed Web of Science ®Google Scholar
• Lymbury RS, Olive C, Powell KA, Good MF, Hirst RG, LaBrooy JT, Ketheesan N. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun 2003; 20:211-7; PMID:12753806; http://dx.doi.org/10.1016/S0896-8411(03)00026-X
   PubMed Web of Science ®Google Scholar
• Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol 2004; 172:3225-34; PMID:14978130; http://dx.doi.org/10.4049/jimmunol.172.5.3225
   PubMed Web of Science ®Google Scholar
• Cunningham MW. T cell mimicry in inflammatory heart disease. Mol Immunol 2004; 40:1121-7; PMID:15036918; http://dx.doi.org/10.1016/j.molimm.2003.11.023
   PubMed Web of Science ®Google Scholar
• Wegmann KW, Zhao W, Griffin AC, Hickey WF. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. J Immunol 1994; 153:892-900; PMID:8021520
   PubMed Web of Science ®Google Scholar
• Rush CM, Govan BL, Sikder S, Williams NL, Ketheesan N. Animal models to investigate the pathogenesis of rheumatic heart disease. Front Pediatr 2014; 2:1-6; PMID:25414841; http://dx.doi.org/10.3389/fped.2014.00116
   PubMedGoogle Scholar
• Houghten RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A 1985; 82:5131-5; PMID:2410914; http://dx.doi.org/10.1073/pnas.82.15.5131
   PubMed Web of Science ®Google Scholar
• Coligan JKA, Margulie D, Shevach E, Strober W. Current protocols in immunology. New York: John Wiley, 1991
   Google Scholar
• Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey. Vaccine 2005; 23:1359-67; PMID:15661384; http://dx.doi.org/10.1016/j.vaccine.2004.09.012
   PubMed Web of Science ®Google Scholar
• Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, Good MF. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8-and diphtheria toxoid-specific antibodies to protection. J Infect Dis 2003; 187:1598-608; PMID:12721940; http://dx.doi.org/10.1086/374800
   PubMed Web of Science ®Google Scholar